INNOVATIVE SURFACE TECHNOLOGIES INC
ST. PAUL, MN · Medtech · Private
Biodegradable nanofiber membrane inserts for 96-well cell culture plates that mimic in vivo tissue microenvironments
- Grants
- $6.9M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $2.2M
- 2 awards · Health and Human S
- #211 of 4531 in medtech
- Patents
- 33
- 12 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 3 same day | Department of Health and Human Services · Phase II · Bioartificial Brain Slices for Drug Screening | $545,626 | |
| Federal grant· 2 of 3 same day | Department of Health and Human Services · Phase II · Ureteral Stent Coatings | $589,930 | |
| Federal grant· 3 of 3 same day | Department of Health and Human Services · Phase II · Bioartificial Brain Slices for Drug Screening | $1,647,821 | |
| Federal grant | Department of Health and Human Services · Phase II · Bioartificial Brain Slices for Drug Screening | $542,765 | |
| Federal grant | Department of Health and Human Services · Phase II · Ureteral Stent Coatings | $590,429 | |
| Federal grant | Department of Health and Human Services · Phase II · Bioartificial Brain Slices for Drug Screening | $559,430 | |
| Federal contract | Department of Health and Human Services · Alternatives To Commercially Available Cell Culture Insert Membranes And Manufacturing Techniques (POP:7/27/2020 To 04/26/2021) | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Ultra-low attachment coatings to maintain CSF shunt patency | $231,993 | |
| Federal grant | Department of Health and Human Services · Phase I · Ultra-low attachment coatings to maintain CSF shunt patency | $231,993 | |
| Federal contract | Department of Health and Human Services · SBIR Phase II, Topic 019: Electrospun Biodegradable Membrane Inserts | $1,972,191 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 208 | BIOSURFACES INC | $2.3M | $900K |
| 209 | Oculogica Inc. | $2.2M | $22M |
| 210 | SAFETRACES, INC | $2.2M | $19M |
| 211 | INNOVATIVE SURFACE TECHNOLOGIES INC | $2.2M | — |
| 212 | Amprion, Inc. | $2.2M | $15M |
| 213 | NeuroPace | $2.2M | $187M |
| 214 | DREAM SYSTEMS, LLC | $2.2M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Silicone Polyurea Block Copolymer Coating Compositions And Methodsgranted
- Polyurea Copolymer Coating Compositions And Methodsapplication
- Polyurea Copolymer Coating Compositions And Methodsgranted
- Polyurea Copolymer Coating Compositions And Methodsgranted
- Silicone Polyurea Block Copolymer Coating Compositions And Methodsgranted
- Tissue Scaffolds For Electrically Excitable Cellsgranted
- Crystallization Inhibitor Compositions for Implantable Urological Devicesgranted
- Coating Agents And Coated Articlesgranted
- Coatings for Controlled Release of Water Soluble Drugsgranted
- Conical Devices For Three-dimensional Aggregate(s) Of Eukaryotic Cellsgranted
- Coatings for Controlled Release of Highly Water Soluble Drugsgranted
- Coating Agents And Coated Articlesgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.